vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
Velocity Financial, Inc. is the larger business by last-quarter revenue ($51.6M vs $37.2M, roughly 1.4× GYRE THERAPEUTICS, INC.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -3.7%, a 71.0% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 32.8%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-5.8M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 17.0%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
GYRE vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $51.6M |
| Net Profit | $-1.4M | $34.8M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | 97.0% |
| Net Margin | -3.7% | 67.3% |
| Revenue YoY | 33.4% | 32.8% |
| Net Profit YoY | -340.1% | 67.0% |
| EPS (diluted) | $-0.01 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $51.6M | ||
| Q3 25 | $30.6M | $49.1M | ||
| Q2 25 | $26.8M | $47.6M | ||
| Q1 25 | $22.1M | $37.5M | ||
| Q4 24 | $27.9M | $38.9M | ||
| Q3 24 | $25.5M | $35.1M | ||
| Q2 24 | $25.2M | $32.4M | ||
| Q1 24 | $27.2M | $29.5M |
| Q4 25 | $-1.4M | $34.8M | ||
| Q3 25 | $5.9M | $25.4M | ||
| Q2 25 | $1.6M | $26.0M | ||
| Q1 25 | $3.7M | $18.9M | ||
| Q4 24 | $569.0K | $20.8M | ||
| Q3 24 | $2.9M | $15.8M | ||
| Q2 24 | $4.5M | $14.8M | ||
| Q1 24 | $9.9M | $17.3M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | 97.0% | ||
| Q3 25 | 22.7% | 72.1% | ||
| Q2 25 | 8.1% | 71.3% | ||
| Q1 25 | 10.3% | 71.7% | ||
| Q4 24 | 2.4% | 82.5% | ||
| Q3 24 | 16.6% | 60.6% | ||
| Q2 24 | 12.7% | 61.3% | ||
| Q1 24 | 29.7% | 78.8% |
| Q4 25 | -3.7% | 67.3% | ||
| Q3 25 | 19.4% | 51.7% | ||
| Q2 25 | 5.9% | 54.6% | ||
| Q1 25 | 16.9% | 50.4% | ||
| Q4 24 | 2.0% | 53.5% | ||
| Q3 24 | 11.2% | 45.1% | ||
| Q2 24 | 18.0% | 45.6% | ||
| Q1 24 | 36.6% | 58.5% |
| Q4 25 | $-0.01 | $0.90 | ||
| Q3 25 | $0.03 | $0.65 | ||
| Q2 25 | $0.00 | $0.69 | ||
| Q1 25 | $0.00 | $0.51 | ||
| Q4 24 | $0.00 | $0.56 | ||
| Q3 24 | $0.01 | $0.44 | ||
| Q2 24 | $0.01 | $0.42 | ||
| Q1 24 | $0.03 | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $92.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $672.5M |
| Total Assets | $166.1M | $7.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $92.1M | ||
| Q3 25 | $60.0M | $99.0M | ||
| Q2 25 | $54.4M | $79.6M | ||
| Q1 25 | $29.9M | $51.7M | ||
| Q4 24 | $26.7M | $49.9M | ||
| Q3 24 | $25.1M | $44.1M | ||
| Q2 24 | $25.1M | $47.4M | ||
| Q1 24 | $37.4M | $34.8M |
| Q4 25 | $106.0M | $672.5M | ||
| Q3 25 | $101.9M | $634.3M | ||
| Q2 25 | $92.0M | $597.9M | ||
| Q1 25 | $68.1M | $563.2M | ||
| Q4 24 | $63.3M | $516.9M | ||
| Q3 24 | $63.2M | $484.6M | ||
| Q2 24 | $60.4M | $471.3M | ||
| Q1 24 | $56.6M | $452.9M |
| Q4 25 | $166.1M | $7.4B | ||
| Q3 25 | $159.4M | $7.0B | ||
| Q2 25 | $152.6M | $6.5B | ||
| Q1 25 | $129.8M | $6.0B | ||
| Q4 24 | $125.4M | $5.5B | ||
| Q3 24 | $125.2M | $5.2B | ||
| Q2 24 | $120.9M | $4.9B | ||
| Q1 24 | $122.0M | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $18.2M |
| Free Cash FlowOCF − Capex | $-5.8M | $17.9M |
| FCF MarginFCF / Revenue | -15.5% | 34.6% |
| Capex IntensityCapex / Revenue | 0.4% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $18.2M | ||
| Q3 25 | $4.7M | $11.5M | ||
| Q2 25 | $2.1M | $7.7M | ||
| Q1 25 | $-129.0K | $3.5M | ||
| Q4 24 | $-2.8M | $37.8M | ||
| Q3 24 | $1.7M | $-17.6M | ||
| Q2 24 | $-5.5M | $11.5M | ||
| Q1 24 | $2.9M | $10.6M |
| Q4 25 | $-5.8M | $17.9M | ||
| Q3 25 | $4.0M | $11.4M | ||
| Q2 25 | $1.8M | $7.6M | ||
| Q1 25 | $-251.0K | $3.5M | ||
| Q4 24 | $-2.8M | $37.5M | ||
| Q3 24 | $1.0M | $-17.6M | ||
| Q2 24 | $-6.9M | $11.4M | ||
| Q1 24 | $2.7M | $10.5M |
| Q4 25 | -15.5% | 34.6% | ||
| Q3 25 | 13.1% | 23.2% | ||
| Q2 25 | 6.8% | 15.9% | ||
| Q1 25 | -1.1% | 9.2% | ||
| Q4 24 | -10.1% | 96.4% | ||
| Q3 24 | 4.1% | -50.3% | ||
| Q2 24 | -27.5% | 35.1% | ||
| Q1 24 | 9.8% | 35.8% |
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 2.2% | 0.1% | ||
| Q2 25 | 1.0% | 0.2% | ||
| Q1 25 | 0.6% | 0.2% | ||
| Q4 24 | 0.2% | 0.7% | ||
| Q3 24 | 2.7% | 0.2% | ||
| Q2 24 | 5.8% | 0.3% | ||
| Q1 24 | 0.9% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | 0.79× | 0.45× | ||
| Q2 25 | 1.32× | 0.29× | ||
| Q1 25 | -0.03× | 0.19× | ||
| Q4 24 | -4.85× | 1.81× | ||
| Q3 24 | 0.60× | -1.11× | ||
| Q2 24 | -1.21× | 0.78× | ||
| Q1 24 | 0.29× | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GYRE
Segment breakdown not available.
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |
